LB Pharmaceuticals, Inc. (LBRX)
43.04
-1.80
(-4.01%)
USD |
NASDAQ |
Sep 15, 16:00
43.90
+0.86
(+2.00%)
After-Hours: 20:00
LB Pharmaceuticals Price to Book Value : 3.714 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 3.714 |
| September 14, 2026 | 3.870 |
| September 11, 2026 | 3.852 |
| September 10, 2026 | 3.991 |
| September 09, 2026 | 4.114 |
| September 08, 2026 | 4.262 |
| September 04, 2026 | 4.258 |
| September 03, 2026 | 4.101 |
| September 02, 2026 | 4.270 |
| September 01, 2026 | 4.065 |
| August 31, 2026 | 4.078 |
| August 28, 2026 | 4.119 |
| August 27, 2026 | 4.133 |
| August 26, 2026 | 4.157 |
| August 25, 2026 | 4.211 |
| August 24, 2026 | 4.160 |
| August 21, 2026 | 4.110 |
| August 20, 2026 | 4.076 |
| August 19, 2026 | 4.224 |
| August 18, 2026 | 4.209 |
| August 17, 2026 | 3.990 |
| August 14, 2026 | 4.123 |
| August 13, 2026 | 3.820 |
| August 12, 2026 | 3.916 |
| August 11, 2026 | 3.912 |
| Date | Value |
|---|---|
| August 10, 2026 | 3.957 |
| August 07, 2026 | 4.142 |
| August 06, 2026 | 4.158 |
| August 05, 2026 | 3.886 |
| August 04, 2026 | 3.883 |
| August 03, 2026 | 3.697 |
| July 31, 2026 | 3.459 |
| July 30, 2026 | 3.530 |
| July 29, 2026 | 3.366 |
| July 28, 2026 | 3.015 |
| July 27, 2026 | 3.002 |
| July 24, 2026 | 3.021 |
| July 23, 2026 | 2.988 |
| July 22, 2026 | 3.093 |
| July 21, 2026 | 2.788 |
| July 20, 2026 | 2.667 |
| July 17, 2026 | 2.711 |
| July 16, 2026 | 2.640 |
| July 15, 2026 | 2.775 |
| July 14, 2026 | 2.763 |
| July 13, 2026 | 2.783 |
| July 10, 2026 | 2.844 |
| July 09, 2026 | 2.912 |
| July 08, 2026 | 2.949 |
| July 07, 2026 | 2.959 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals, Inc. | 5.703 |
| Neumora Therapeutics, Inc. | 3.489 |
| ANI Pharmaceuticals, Inc. | 2.774 |
| Corcept Therapeutics, Inc. | 16.95 |
| Veru, Inc. | 1.406 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1093 |
| Price | 43.04 |
| Earnings Yield | -6.93% |
| Market Cap | 1.234B |
| PEGY Ratio | -0.1093 |